Nanoparticles as Adjuvants and Nanodelivery Systems for mRNA-Based Vaccines
Messenger RNA (mRNA)-based vaccines have shown promise against infectious diseases and several types of cancer in the last two decades.Their promise can be attributed to their safety profiles, high potency, and ability to be rapidly and affordably manufactured.Now, many RNA-based vaccines are being evaluated in clinical trials as prophylactic and t